Cargando…
Allosteric inhibition of carnosinase (CN1) by inducing a conformational shift
In humans, low serum carnosinase (CN1) activity protects patients with type 2 diabetes from diabetic nephropathy. We now characterized the interaction of thiol-containing compounds with CN1 cysteine residue at position 102, which is important for CN1 activity. Reduced glutathione (GSH), N-acetylcyst...
Autores principales: | Peters, Verena, Schmitt, Claus P., Weigand, Tim, Klingbeil, Kristina, Thiel, Christian, van den Berg, Antje, Calabrese, Vittorio, Nawroth, Peter, Fleming, Thomas, Forsberg, Elisabete, Wagner, Andreas H., Hecker, Markus, Vistoli, Giulio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6009930/ https://www.ncbi.nlm.nih.gov/pubmed/28776438 http://dx.doi.org/10.1080/14756366.2017.1355793 |
Ejemplares similares
-
Carnosinase-1 Knock-Out Reduces Kidney Fibrosis in Type-1 Diabetic Mice on High Fat Diet
por: Pfeffer, Tilman, et al.
Publicado: (2023) -
Carnosinases, Their Substrates and Diseases
por: Bellia, Francesco, et al.
Publicado: (2014) -
Protective Actions of Anserine Under Diabetic Conditions
por: Peters, Verena, et al.
Publicado: (2018) -
Monoclonal Antibody RYSK173 Recognizes the Dinuclear Zn Center of Serum Carnosinase 1 (CN-1): Possible Consequences of Zn Binding for CN-1 Recognition by RYSK173
por: Zhang, Shiqi, et al.
Publicado: (2016) -
Correction: Monoclonal Antibody RYSK173 Recognizes the Dinuclear Zn Center of Serum Carnosinase 1 (CN-1): Possible Consequences of Zn Binding for CN-1 Recognition by RYSK173
por: Zhang, Shiqi, et al.
Publicado: (2017)